5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.94▼ | 9.86▲ | 9.77▲ | 9.31▲ | 8.57▲ |
MA10 | 9.97▼ | 9.75▲ | 9.60▲ | 8.86▲ | 7.77▲ |
MA20 | 9.87▼ | 9.54▲ | 9.36▲ | 8.48▲ | 6.61▲ |
MA50 | 9.73▲ | 9.18▲ | 8.90▲ | 7.53▲ | 7.55▲ |
MA100 | 9.53▲ | 8.84▲ | 8.57▲ | 6.47▲ | 9.66▲ |
MA200 | 9.28▲ | 8.53▲ | 8.43▲ | 6.88▲ | 22.70▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | 0.029▲ | 0.046▲ | 0.100▲ | 0.495▲ |
RSI | 51.611▲ | 63.443▲ | 66.529▲ | 71.874▲ | 64.876▲ |
STOCH | 50.392 | 78.229 | 87.015▲ | 84.423▲ | 77.840 |
WILL %R | -47.253 | -29.252 | -19.635▲ | -9.840▲ | -3.528▲ |
CCI | -31.607 | 103.293▲ | 119.698▲ | 207.349▲ | 114.388▲ |
Thursday, May 01, 2025 01:05 PM
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, ...
|
Wednesday, April 23, 2025 05:30 AM
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp (OPRX). (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions ...
|
Monday, April 21, 2025 05:46 AM
In a report released today, Eric Martinuzzi from Lake Street maintained a Buy rating on OptimizeRx (OPRX – Research Report), with a price ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 9.91 | 10.085 | 9.87 | 9.87 | 29,727 |
01/05/25 | 9.13 | 9.90 | 8.935 | 9.64 | 271,106 |
30/04/25 | 8.97 | 9.32 | 8.65 | 9.12 | 146,005 |
29/04/25 | 8.67 | 9.25 | 8.67 | 9.18 | 124,183 |
28/04/25 | 8.65 | 8.97 | 8.59 | 8.74 | 136,124 |
25/04/25 | 8.27 | 8.86 | 8.14 | 8.66 | 144,233 |
24/04/25 | 8.46 | 8.60 | 8.37 | 8.38 | 100,008 |
23/04/25 | 8.47 | 8.9185 | 8.30 | 8.41 | 150,324 |
22/04/25 | 8.37 | 8.5387 | 8.09 | 8.20 | 141,166 |
21/04/25 | 8.56 | 8.8072 | 8.23 | 8.38 | 85,953 |
|
|
||||
|
|
||||
|
|